Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

The challenge of implant integration in partial meniscal replacement: an experimental study on a silk fibroin scaffold in sheep.

Stein SEC, von Luebken F, Warnecke D, Gentilini C, Skaer N, Walker R, Kessler O, Ignatius A, Duerselen L.

Knee Surg Sports Traumatol Arthrosc. 2018 Sep 27. doi: 10.1007/s00167-018-5160-7. [Epub ahead of print]

PMID:
30264241
2.

Semaphorin-3A inhibits multiple myeloma progression in a mouse model.

Lavi N, Kessler O, Ziv K, Nir-Zvi I, Mumblat Y, Eiza N, Paran Y, Brenner B, Vadasz Z, Neufeld G.

Carcinogenesis. 2018 Oct 8;39(10):1283-1291. doi: 10.1093/carcin/bgy106.

PMID:
30102336
3.

Combined Calorimetry, Thermo-Mechanical Analysis and Tensile Test on Welded EN AW-6082 Joints.

Wiechmann P, Panwitt H, Heyer H, Reich M, Sander M, Kessler O.

Materials (Basel). 2018 Aug 9;11(8). pii: E1396. doi: 10.3390/ma11081396.

4.

Biomechanical, structural and biological characterisation of a new silk fibroin scaffold for meniscal repair.

Warnecke D, Stein S, Haffner-Luntzer M, de Roy L, Skaer N, Walker R, Kessler O, Ignatius A, Dürselen L.

J Mech Behav Biomed Mater. 2018 Oct;86:314-324. doi: 10.1016/j.jmbbm.2018.06.041. Epub 2018 Jun 30.

5.

Semaphorin3A: A Potential Therapeutic Tool for Lupus Nephritis.

Bejar J, Kessler O, Sabag AD, Sabo E, Itzhak OB, Neufeld G, Vadasz Z.

Front Immunol. 2018 Apr 4;9:634. doi: 10.3389/fimmu.2018.00634. eCollection 2018.

6.

Complexes of plexin-A4 and plexin-D1 convey semaphorin-3C signals to induce cytoskeletal collapse in the absence of neuropilins.

Smolkin T, Nir-Zvi I, Duvshani N, Mumblat Y, Kessler O, Neufeld G.

J Cell Sci. 2018 May 4;131(9). pii: jcs208298. doi: 10.1242/jcs.208298.

7.

Correction to: In vivo performance of a novel silk fibroin scaffold for partial meniscal replacement in a sheep model.

Gruchenberg K, Ignatius A, Friemert B, von Lübken F, Skaer N, Gellynck K, Kessler O, Dürselen L.

Knee Surg Sports Traumatol Arthrosc. 2018 Jul;26(7):2216. doi: 10.1007/s00167-018-4878-6.

PMID:
29480406
8.

Mechanical Properties of a Newly Additive Manufactured Implant Material Based on Ti-42Nb.

Schulze C, Weinmann M, Schweigel C, Keßler O, Bader R.

Materials (Basel). 2018 Jan 13;11(1). pii: E124. doi: 10.3390/ma11010124.

9.

Friction properties of a new silk fibroin scaffold for meniscal replacement.

Warnecke D, Schild NB, Klose S, Joos H, Brenner RE, Kessler O, Skaer N, Walker R, Freutel M, Ignatius A, Dürselen L.

Tribol Int. 2017 May;109:586-592. doi: 10.1016/j.triboint.2017.01.038.

10.

Function and strain of the anterolateral ligament part I: biomechanical analysis.

Drews BH, Kessler O, Franz W, Dürselen L, Freutel M.

Knee Surg Sports Traumatol Arthrosc. 2017 Apr;25(4):1132-1139. doi: 10.1007/s00167-017-4472-3. Epub 2017 Mar 3.

PMID:
28258329
11.

A Sema3C Mutant Resistant to Cleavage by Furin (FR-Sema3C) Inhibits Choroidal Neovascularization.

Toledano S, Lu H, Palacio A, Ziv K, Kessler O, Schaal S, Neufeld G, Barak Y.

PLoS One. 2016 Dec 30;11(12):e0168122. doi: 10.1371/journal.pone.0168122. eCollection 2016.

12.

The semaphorins and their receptors as modulators of tumor progression.

Neufeld G, Mumblat Y, Smolkin T, Toledano S, Nir-Zvi I, Ziv K, Kessler O.

Drug Resist Updat. 2016 Nov;29:1-12. doi: 10.1016/j.drup.2016.08.001. Epub 2016 Aug 28. Review.

PMID:
27912840
13.

A SEMA3E mutant resistant to cleavage by furins (UNCL-SEMA3E) inhibits choroidal neovascularization.

Toledano S, Lu H, Palacio A, Kigel B, Kessler O, Allon G, Barak Y, Neufeld G, Schaal S.

Exp Eye Res. 2016 Dec;153:186-194. doi: 10.1016/j.exer.2016.10.004. Epub 2016 Oct 7.

PMID:
27725196
14.

Dormant tumor cells expressing LOXL2 acquire a stem-like phenotype mediating their transition to proliferative growth.

Weidenfeld K, Schif-Zuck S, Abu-Tayeh H, Kang K, Kessler O, Weissmann M, Neufeld G, Barkan D.

Oncotarget. 2016 Nov 1;7(44):71362-71377. doi: 10.18632/oncotarget.12109.

15.

The role of the semaphorins in cancer.

Neufeld G, Mumblat Y, Smolkin T, Toledano S, Nir-Zvi I, Ziv K, Kessler O.

Cell Adh Migr. 2016 Nov;10(6):652-674. Epub 2016 Aug 17. Review.

16.

Vapor pressure of ionic liquids at low temperatures from AC-chip-calorimetry.

Ahrenberg M, Beck M, Neise C, Keßler O, Kragl U, Verevkin SP, Schick C.

Phys Chem Chem Phys. 2016 Aug 3;18(31):21381-90. doi: 10.1039/c6cp01948j.

PMID:
27425628
17.

Localized LoxL3-Dependent Fibronectin Oxidation Regulates Myofiber Stretch and Integrin-Mediated Adhesion.

Kraft-Sheleg O, Zaffryar-Eilot S, Genin O, Yaseen W, Soueid-Baumgarten S, Kessler O, Smolkin T, Akiri G, Neufeld G, Cinnamon Y, Hasson P.

Dev Cell. 2016 Mar 7;36(5):550-61. doi: 10.1016/j.devcel.2016.02.009.

18.

In-situ investigation of stress conditions during expansion of bare metal stents and PLLA-coated stents using the XRD sin(2)ψ-technique.

Kowalski W, Dammer M, Bakczewitz F, Schmitz KP, Grabow N, Kessler O.

J Mech Behav Biomed Mater. 2015 Sep;49:23-9. doi: 10.1016/j.jmbbm.2015.04.020. Epub 2015 Apr 24.

PMID:
25974098
19.

Full-Length Semaphorin-3C Is an Inhibitor of Tumor Lymphangiogenesis and Metastasis.

Mumblat Y, Kessler O, Ilan N, Neufeld G.

Cancer Res. 2015 Jun 1;75(11):2177-86. doi: 10.1158/0008-5472.CAN-14-2464. Epub 2015 Mar 25.

20.

Higher strains in the inner region of the meniscus indicate a potential source for degeneration.

Kessler O, Sommers M, Augustin T, Haybaeck J, D'Lima DD, Madey SM, Bottlang M.

J Biomech. 2015 Jun 1;48(8):1377-82. doi: 10.1016/j.jbiomech.2015.02.059. Epub 2015 Mar 11.

PMID:
25801421
21.

The role of the plexin-A2 receptor in Sema3A and Sema3B signal transduction.

Sabag AD, Smolkin T, Mumblat Y, Ueffing M, Kessler O, Gloeckner CJ, Neufeld G.

J Cell Sci. 2014 Dec 15;127(Pt 24):5240-52. doi: 10.1242/jcs.155960. Epub 2014 Oct 21.

22.

Strong correlation between the morphology of the proximal femur and the geometry of the distal femoral trochlea.

Wright SJ, Boymans TA, Grimm B, Miles AW, Kessler O.

Knee Surg Sports Traumatol Arthrosc. 2014 Dec;22(12):2900-10. doi: 10.1007/s00167-014-3343-4. Epub 2014 Oct 2.

PMID:
25274089
23.

Global analysis of saliva as a source of bacterial genes for insights into human population structure and migration studies.

Henne K, Li J, Stoneking M, Kessler O, Schilling H, Sonanini A, Conrads G, Horz HP.

BMC Evol Biol. 2014 Aug 22;14:190. doi: 10.1186/s12862-014-0190-3.

24.

In vivo performance of a novel silk fibroin scaffold for partial meniscal replacement in a sheep model.

Gruchenberg K, Ignatius A, Friemert B, von Lübken F, Skaer N, Gellynck K, Kessler O, Dürselen L.

Knee Surg Sports Traumatol Arthrosc. 2015 Aug;23(8):2218-2229. doi: 10.1007/s00167-014-3009-2. Epub 2014 Apr 26. Erratum in: Knee Surg Sports Traumatol Arthrosc. 2018 Feb 26;:.

25.

Isothermal Time-Temperature-Precipitation Diagram for an Aluminum Alloy 6005A by In Situ DSC Experiments.

Milkereit B, Giersberg L, Kessler O, Schick C.

Materials (Basel). 2014 Mar 28;7(4):2631-2649. doi: 10.3390/ma7042631.

26.

Determination of volatility of ionic liquids at the nanoscale by means of ultra-fast scanning calorimetry.

Ahrenberg M, Brinckmann M, Schmelzer JW, Beck M, Schmidt C, Kessler O, Kragl U, Verevkin SP, Schick C.

Phys Chem Chem Phys. 2014 Feb 21;16(7):2971-80. doi: 10.1039/c3cp54325k.

PMID:
24390395
27.

Lysyl oxidase-like-2 promotes tumour angiogenesis and is a potential therapeutic target in angiogenic tumours.

Zaffryar-Eilot S, Marshall D, Voloshin T, Bar-Zion A, Spangler R, Kessler O, Ghermazien H, Brekhman V, Suss-Toby E, Adam D, Shaked Y, Smith V, Neufeld G.

Carcinogenesis. 2013 Oct;34(10):2370-9. doi: 10.1093/carcin/bgt241. Epub 2013 Jul 4.

PMID:
23828904
28.

T-RFLP-based differences in oral microbial communities as risk factor for development of oral diseases under stress.

Horz HP, Ten Haaf A, Kessler O, Said Yekta S, Seyfarth I, Hettlich M, Lampert F, Küpper T, Conrads G.

Environ Microbiol Rep. 2012 Aug;4(4):390-7. doi: 10.1111/j.1758-2229.2012.00340.x. Epub 2012 Mar 29.

PMID:
23760823
29.

Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosus.

Vadasz Z, Haj T, Halasz K, Rosner I, Slobodin G, Attias D, Kessel A, Kessler O, Neufeld G, Toubi E.

Arthritis Res Ther. 2012 Jun 14;14(3):R146. doi: 10.1186/ar3881.

30.

Clinical risk management in hospitals: strategy, central coordination and dialogue as key enablers.

Briner M, Manser T, Kessler O.

J Eval Clin Pract. 2013 Apr;19(2):363-9. doi: 10.1111/j.1365-2753.2012.01836.x. Epub 2012 Mar 13.

PMID:
22409240
31.

Semaphorins in angiogenesis and tumor progression.

Neufeld G, Sabag AD, Rabinovicz N, Kessler O.

Cold Spring Harb Perspect Med. 2012 Jan;2(1):a006718. doi: 10.1101/cshperspect.a006718. Review.

32.

Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform.

Casazza A, Kigel B, Maione F, Capparuccia L, Kessler O, Giraudo E, Mazzone M, Neufeld G, Tamagnone L.

EMBO Mol Med. 2012 Mar;4(3):234-50. doi: 10.1002/emmm.201100205. Epub 2012 Jan 13.

33.

The enzymatic activity of lysyl oxidas-like-2 (LOXL2) is not required for LOXL2-induced inhibition of keratinocyte differentiation.

Lugassy J, Zaffryar-Eilot S, Soueid S, Mordoviz A, Smith V, Kessler O, Neufeld G.

J Biol Chem. 2012 Jan 27;287(5):3541-9. doi: 10.1074/jbc.M111.261016. Epub 2011 Dec 8.

34.

Plexin-A4 promotes tumor progression and tumor angiogenesis by enhancement of VEGF and bFGF signaling.

Kigel B, Rabinowicz N, Varshavsky A, Kessler O, Neufeld G.

Blood. 2011 Oct 13;118(15):4285-96. doi: 10.1182/blood-2011-03-341388. Epub 2011 Aug 10.

35.

Effect of meniscus replacement fixation technique on restoration of knee contact mechanics and stability.

D'Lima DD, Chen PC, Kessler O, Hoenecke HR, Colwell CW Jr.

Mol Cell Biomech. 2011 Jun;8(2):123-34.

PMID:
21608413
36.

Assessing hospitals' clinical risk management: Development of a monitoring instrument.

Briner M, Kessler O, Pfeiffer Y, Wehner T, Manser T.

BMC Health Serv Res. 2010 Dec 13;10:337. doi: 10.1186/1472-6963-10-337.

37.

Receptor activity modifying protein-3 mediates the protumorigenic activity of lysyl oxidase-like protein-2.

Brekhman V, Lugassie J, Zaffryar-Eilot S, Sabo E, Kessler O, Smith V, Golding H, Neufeld G.

FASEB J. 2011 Jan;25(1):55-65. doi: 10.1096/fj.10-162677. Epub 2010 Aug 27.

PMID:
20802105
38.

A useful radiologic method for preoperative joint-line determination in revision total knee arthroplasty.

Romero J, Seifert B, Reinhardt O, Ziegler O, Kessler O.

Clin Orthop Relat Res. 2010 May;468(5):1279-83. doi: 10.1007/s11999-009-1114-1. Epub 2009 Nov 5.

39.

A prospective randomized assessment of earlier functional recovery in THA patients treated by minimally invasive direct anterior approach: a gait analysis study.

Mayr E, Nogler M, Benedetti MG, Kessler O, Reinthaler A, Krismer M, Leardini A.

Clin Biomech (Bristol, Avon). 2009 Dec;24(10):812-8. doi: 10.1016/j.clinbiomech.2009.07.010. Epub 2009 Aug 21.

PMID:
19699566
40.

A method to quantify alteration of knee kinematics caused by changes of TKR positioning.

Kessler O, Bull AM, Amis AA.

J Biomech. 2009 Apr 16;42(6):665-70. doi: 10.1016/j.jbiomech.2009.01.006. Epub 2009 Mar 6.

41.

The effect of femoral component malrotation on patellar biomechanics.

Kessler O, Patil S, Colwell CW Jr, D'Lima DD.

J Biomech. 2008 Dec 5;41(16):3332-9. doi: 10.1016/j.jbiomech.2008.09.032. Epub 2008 Nov 18.

PMID:
19019376
42.

Successful inhibition of tumor development by specific class-3 semaphorins is associated with expression of appropriate semaphorin receptors by tumor cells.

Kigel B, Varshavsky A, Kessler O, Neufeld G.

PLoS One. 2008 Sep 26;3(9):e3287. doi: 10.1371/journal.pone.0003287.

43.

Semaphorin-3B is an angiogenesis inhibitor that is inactivated by furin-like pro-protein convertases.

Varshavsky A, Kessler O, Abramovitch S, Kigel B, Zaffryar S, Akiri G, Neufeld G.

Cancer Res. 2008 Sep 1;68(17):6922-31. doi: 10.1158/0008-5472.CAN-07-5408.

44.

Changes in knee kinematics reflect the articular geometry after arthroplasty.

Bull AM, Kessler O, Alam M, Amis AA.

Clin Orthop Relat Res. 2008 Oct;466(10):2491-9. doi: 10.1007/s11999-008-0440-z. Epub 2008 Aug 13.

45.

Neuropilin-1-VEGFR-2 complexing requires the PDZ-binding domain of neuropilin-1.

Prahst C, Héroult M, Lanahan AA, Uziel N, Kessler O, Shraga-Heled N, Simons M, Neufeld G, Augustin HG.

J Biol Chem. 2008 Sep 12;283(37):25110-4. doi: 10.1074/jbc.C800137200. Epub 2008 Jul 15.

46.

The semaphorins: versatile regulators of tumour progression and tumour angiogenesis.

Neufeld G, Kessler O.

Nat Rev Cancer. 2008 Aug;8(8):632-45. doi: 10.1038/nrc2404. Epub 2008 Jun 26. Review.

PMID:
18580951
47.

Bony impingement affects range of motion after total hip arthroplasty: A subject-specific approach.

Kessler O, Patil S, Wirth S, Mayr E, Colwell CW Jr, D'Lima DD.

J Orthop Res. 2008 Apr;26(4):443-52. Erratum in: J Orthop Res. 2008 Oct;26(10):1419. Stefan, Wirth [corrected to Wirth, Stephan].

48.

Semaphorin signaling in vascular and tumor biology.

Neufeld G, Lange T, Varshavsky A, Kessler O.

Adv Exp Med Biol. 2007;600:118-31. Review.

PMID:
17607951
49.

Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis.

Guttmann-Raviv N, Shraga-Heled N, Varshavsky A, Guimaraes-Sternberg C, Kessler O, Neufeld G.

J Biol Chem. 2007 Sep 7;282(36):26294-305. Epub 2007 Jun 14.

50.

Supplemental Content

Loading ...
Support Center